Are neratinib (He Li'an) and neratinib the same drug?

When many patients learn about HER2-positive targeted therapy for breast cancer, they often wonder whether neratinib (Neratinib) and neratinib are different drugs. In fact, the two are essentially the same drug, just with different names and translations. Neratinib is the international common name (INN). When it was launched in mainland China, its Chinese trade name was "Heli'an" and its chemical name was "neratinib maleate tablets". "Neratinib" is the transliterated name of the drug in some early literature, clinical data and overseas reports, so neratinib and neratinib refer to the same compound.

Neratinib is a second-generation HER2-targeted small molecule drug. Compared with the early trastuzumab or lapatinib, its advantage is that it can irreversibly inhibit multiple signaling pathways in the HER family and has a more lasting inhibitory effect on HER2-mutated breast cancer cells. The clinical application of this drug is mainly focused on the extended treatment phase after surgery for HER2-positive early breast cancer to reduce the risk of recurrence. In addition, some studies are also exploring its potential application in other solid tumors with HER2 mutations, such as lung cancer or biliary tract cancer.

In the Chinese market, neratinib was introduced by Pfizer and officially approved for marketing in recent years, becoming another important HER2-targeted drug after trastuzumab and pertuzumab. Its main specification is 40mg*180 tablets, and patients can enjoy partial cost reduction after being included in medical insurance. The drug instructions clearly state that the drug should be used under the guidance of a doctor, and attention should be paid to common adverse reactions such as diarrhea and abnormal liver function.

The "neratinib", "neratinib", "NERLYNX" and "He Li'an" appearing on the market are all different names of the same drug. Whether it is an imported original drug or an overseas generic version, the main ingredient is neratinib, but there are differences in dosage form, packaging and sales channels.

Reference materials:https://en.wikipedia.org/wiki/Neratinib